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1. Abstract  
Duchenne muscular dystrophy (DMD) affects approximately 1 in 5,000 males. DMD 
results from genetic mutations within the gene that interrupts the open reading frame and 
prematurely truncates the protein. From a non-functional dystrophin protein, DMD results in 
serious muscle weakening and muscle wasting ultimately leading to death around the age of 26. 
In some cases of muscular dystrophy, a mutation can occur in areas of the gene that are less 
essential. In Becker muscular dystrophy (BMD), these mutations cause less significant 
consequences in phenotype as the dystrophin protein is still semi-functional. With gene editing 
techniques, it may be possible to reduce the consequences of the DMD phenotype. Exon 
skipping is a process that advertently skips specific and surrounding exons that have been 
harmfully mutated. This process could potentially be used to skip specific exons in the DMD 
gene necessary to bring the RNA transcript back into the correct reading frame. This study 
focuses on the theoretical application of exon skipping in DMD. Using data of all the recorded 
mutations up to now, the study looks at the separate effects skipping each exon has on the three 
different types of mutations: deletions, duplications, and small rearrangements. Exon skipping 
was modeled computationally. Under an important operational assumption, the results were 
encouraging. Theoretically, skipping the top eight most effective exons would correctly reframe 
just above 50% of the total mutations. Skipping exon 51 alone would restore the reading frame in 
14% of patients. This study focused primarily on the results of skipping only one exon at a time. 
While there is still much more work to do to find the true applicability of exon skipping in DMD, 
the results provide a solid framework and guide to what comes next.  
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2. Introduction  
2.1 Muscular Dystrophy 
 Duchenne muscular dystrophy (DMD) is an X-linked recessive genetic disorder found in 
approximately 1 in 5,000 males (NIH, 2016). The genetic disorder is caused by mutations in the 
DMD gene leading to premature truncation of the gene. The DMD gene is 79 exons long and is 
responsible for the production of the dystrophin protein. When complete, this protein is used to 
strengthen muscle fibers and protect them from injury as muscles contract and relax (NIH, 2017). 
When a mutation causes the gene to be non-functional, the consequences in the corresponding 
phenotype can be devastating. Motor skills suffer initially as muscle weakness and muscle 
wasting occurs in the voluntary muscles. As it progresses, this degenerative disease eventually 
leads to the loss of ambulation of those affected. Involuntary and cardiac muscles are also 
weakened leading to the eventual death of the patient. The average life expectancy associated 
with DMD is 26 years.  
In some cases of muscular dystrophy, a mutation can occur in areas of the gene that are 
less essential. In Becker muscular dystrophy (BMD), these mutations cause less significant 
consequences in phenotype as the dystrophin protein is still semi-functional. With a significantly 
longer life expectancy and greater quality of living, BMD clearly results in better conditions for 
patients than does DMD. This provided the basis for a potential DMD treatment. Becker 
muscular dystrophy shows that the DMD gene can still produce functional dystrophin proteins 
when the mutation does not result in catastrophic frameshifts, premature truncation, or occur in 
highly important areas of the gene. With this information, a gene editing approach has been 
proposed to reframe the exons of a DMD gene to prevent a typical DMD phenotype. 
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2.2. CRISPR and Exon Skipping 
A common approach to gene editing has been with the use of clustered regularly 
interspaced short palindromic repeats or CRISPR. CRISPR is a bacterial immune system capable 
of producing double strand breaks in target DNA. A clinical approach for CRISPR has been 
producing double-strand breaks in a target gene and allowing the cell to repair to form small 
insertions or deletions (indels). These indels can be used to knock out target exons in a manner 
similar to antisense-mediated exon skipping.  
In Duchenne muscular dystrophy, there is often an exon or group of exons that are 
mutated. This disrupts the open-reading frame and often results in a non-functional protein 
(Aartsma-Rus, 2006). Examples from Becker muscular dystrophy, however, show that the 
protein can still be functional even while missing some of its non-essential regions. With this 
concept, exon skipping provides a hopeful tool for DMD by skipping necessary exons to bring 
the RNA transcript back into the correct reading frame. This study aims to show the theoretical 
applicability of using this technique in regards to how many currently recorded cases of DMD 
would undergo a reading-frame restoration through the skipping of a single exon.   
 
3. Materials and Methods 
3.1. Data Formatting 
All of the data was obtained from the UMD website (UMD, n.d.). 7,150 records are 
broken up into 1,733 different mutations. Information pertaining to the protein nomenclature, 
cDNA nomenclature, the exon and codon affected, structure within the gene, type of 
rearrangement, and number of records for each mutation is all provided. The data was copied 
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into Microsoft Excel for further manipulation. Using basic Excel functions, the data was 
separated by mutation and sorted from most common to least common.  
Figure 1: Each mutation was organized using the 9 categories shown above 
 
3.2. Mapping the Mutations 
The next step was to model the mutations within the 79 exons of the DMD gene. The 
exon structure of the gene was plotted out to the right of the mutational data. Exons 1-79 were 
used as column headers. There were three main types of mutations: deletions, duplications, and 
small rearrangements. For each mutation, the cell that was representing the exon or exons 
affected was shaded in. This was done using a binary number system. Each cell contained either 
a 0 or a 1. If it contained a 0, it was not shaded in. If it contained a 1, the cell was shaded 
representing a mutation of that exon.  
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Figure 2: A portion of the mutation map between exons 45 and 54. 
 
 In order to map the placement of each mutation, the data on the range of affected exons 
needed to be isolated. Most rows of the “Rearrangement” column included the range of exons 
which the mutation affected (“from exon # to #). Each row of the “Rearrangement” column was 
searched for the word “exon” (Eq 1). The following numeric value was extracted from the cell 
(Eq 2). Again the column was searched up to the number of the ending exon and then extracted 
out as well using similar search, mid, and value functions (Eq 3 and 4). Once the exon numbers 
were isolated, each mutation was sifted through exon by exon and assigned a 0 or a 1 for each 
exon on the exon map. This was done using the product of two “If” logic functions (Eq 5). If the 
exon number was greater than or equal to the first exon number isolated in that row, then it was 
assigned a 1. If the exon number was less than or equal to the last exon number isolated in that 
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row, then it was also assigned a 1. All other exons for each mutation was given a value of 0. 
Simple conditional formatting shaded in the cells with a value of 1. This allowed the affected 
area of the gene to be clearly represented with shaded cells for each mutation.  
 
Formula 1: =SEARCH("exon ",G4,1) 
Formula 2: =VALUE(MID(G4,L4+5,2)) 
Formula 3: =SEARCH(" to ",G4,"1") 
Formula 4: =VALUE(MID(G4,N4+4,2)) 
Formula 5: =IF(S$3>=$M4,1,0)*IF(S$3<=$O4,1,0) 
 
3.3. Modelling Exon Skipping 
After mapping the mutations on the excel sheet, it was necessary to look at the results of 
skipping individual exons. To do this, the structure and reading frame of each exon needed to be 
represented. Common literature often depicts this by using exons with shaped ends 
corresponding to the next exon. To model this compatibility, each exon was assigned two 
reading-frame numbers, 1-3, with each number corresponding to the shape of both the 5’ and 3’ 
end of the exon.  
 
Figure 3: Normal reading frame of the DMD gene from exon 68 to exon 75 (Muscular 
Dystrophy UK, 2015) 
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Figure 4: Deleted exon 52 causing a frameshift and prematurely truncating the protein 
(Muscular Dystrophy UK, 2015) 
  
Figure 5: Illustration of reading frame numbers assigned to the individual exons 
 
Modelling the exon skipping approach was different depending on the type of mutation. 
For the deletions, the approach needed to be broken down in two parts: skipping the exon before 
the mutation and after the mutation. Combining these two would result in the theoretical 
applicability of skipping each exon. For the duplications, this study focused on single exon 
duplications as multiple exon deletions would likely require skipping more than one exon (Niks, 
2017). Finally, for the small rearrangements, the exon skipped was the one with the 
rearrangement and thus causing an out-of-frame mutation. An important operating assumption 
made initially was that this study was going to neglect where in the gene the mutation and 
skipping was taking place. Thus, it looked at only restoring the reading frame and saved 
analyzing the phenotypic consequences for a future study.  
Beginning with skipping one exon before a deletion, each row was searched to find the 
first affected exon and then extracted the exon two before that (Eq 6). The 3’ reading-frame 
number assigned to that exon was isolated and saved for later comparison (Eq 7 and 8). Next, the 
same row was searched for the last affected exon and the exon after was extracted (Eq 9). The 5’ 
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reading-frame number assigned to that exon was isolated and compared to the 3’ reading-frame 
number of the first isolated exon (Eq 7 and 8). The two reading-frame numbers were analyzed 
using a simple “If” logical formula: if the two numbers were equal, then that row would be 
labelled “true”. If the two numbers were not equal, then that row would be labelled “false” (Eq 
10). This process was repeated again but instead of skipping the exon before the deletion, the 
exon after the deletion was skipped (Eq 7, 8, 10, 11, and 12). Of the results that were labelled 
“true”, the exon skipped and the number of records of that mutation were organized into a pivot 
table and then graphed accordingly.  
 
Formula 6: =MATCH(1,U4:CU4,0) -2 
Formula 7: =INDEX($S$2:$CS$3,1,CU4) 
Formula 8: =MID(CV4,4,4) 
Formula 9: =LOOKUP(2,1/(S4:CS4<>0),$S$3:$CS$3)+1 
Formula 10: =IF(CW4=CZ4,"true", "false") 
Formula 11: =MATCH(1,U4:CU4,0) -1 
Formula 12: = LOOKUP(2,1/(S4:CS4<>0),$S$3:$CS$3)+2 
 
 For the duplications, a similar strategy was used. Each row was searched for the two 
exons on either side of the duplicated exon (Eq 9 and 11). The number of exons duplicated were 
calculated by subtracting the two exons on either side. Since the study is looking at duplications 
only affecting one exon, mutations that contained duplications longer than a single exon were 
filtered out. A pivot table was created consisting of the number of records from each skipped 
exon.  
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The process used for the small arrangements was only slightly different than what was 
used for the deletions. The two exons on the 5’ and 3’ sides of the affected area were isolated 
using equations 9 and 11. The two reading-frame numbers assigned to the isolated exons were 
extracted and compared in similar fashion to the deletion process (Eq 7, 8, and 10). Once each 
mutation was labelled “true” or “false” based on the restoration of the reading frame, all of the 
true results were organized into a pivot table displaying the number of records for each skipped 
exon.  
  
4. Results 
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Figure 6: This graph depicts the amount of recorded deletion-type mutation cases of DMD that 
would theoretically have their reading-frame restored through a single exon skip. Skipping each 
individual exon, excluding the first and the last (1 and 79), yielded different results depending on 
where the deletions were occurring within the gene. 
 
Figure 7: This graph shows the amount of recorded duplication-type mutation cases of 
DMD that would theoretically have their reading-frame restored through a single exon 
skip. Skipping each individual exon, excluding the first and the last (1 and 79), yielded 
different results depending on where the deletions were occurring within the gene. With 
duplications, only one of the two copies of an exon was skipped. 
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Figure 8: The above graph illustrates the amount of small rearrangement mutation cases 
that would theoretically have their reading-frame restored through a single exon skip. 
Skipping each individual exon, excluding the first and the last (1 and 79), yielded 
different results depending on where the deletions were occurring within the gene. This 
study focused on the mutations with small rearrangements in one exon. 
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Figure 9: This figure represents every recorded case of DMD, regardless of the mutation 
type, that would theoretically have their reading-frame restored through a single exon 
skip. Skipping each individual exon, excluding the first and the last (1 and 79), yielded 
different results depending on where the deletions were occurring within the gene. This 
graph combined the results of figures 6, 7, and 8. 
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5. Discussion 
 The four graphs above show the theoretical results of exon skipping in three different 
types of mutations. Figure 6 shows the results of exon skipping for deletions of at least one exon. 
This group contained the largest number of records, 4903, and consisted of 506 different 
deletions. The graph also illustrates a hotspot for deletions between exons 43 and 55, thus 
skipping exons within this range affects the largest number of cases. Seen in Figure 6, exon 51 
theoretically restores the reading-frame in 1001 cases out of 4903 deletions and 7150 total 
mutations for about 14% of all DMD mutations.  
 Figure 7 shows the results from the application of exon skipping to duplication mutations 
in DMD. The number of one exon duplications was significantly less than deletions; however, 
there is still a slight cluster of cases between exons 2 and 7 and also exons 43 and 55. On the 
other end of the gene, exon 2 is a commonly duplicated exon. Luckily, a deletion of exon 2 
restores the genetic reading-frame in 90 cases. While there are six times more deletions than 
duplications, the strategy for exon skipping in duplication mutations is less straightforward. 
Single exon duplications require only one copy of the mutated exon to be skipped: either the 
original or duplicated exon. At the same time if both copies of the exon are skipped, it can lead 
to an out-of-frame transcript. Mutations involving multiple exon duplications often require 
multiple exons to be skipped and can be very challenging. Exploring other gene editing strategies 
would potentially yield better results for multiple exon duplications.  
Figure 8 graphs the results from individual exon skipping in the small rearrangement 
mutations found in DMD. The results from this group of mutations were relatively even across 
the 79 exons. Two slight peaks can be seen from exons 14 to 23 and from exons 32 to 41. In 
single exon rearrangements, the reading-frame can often be restored by skipping the exon that 
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has been rearranged and thus has caused an out-of-frame transcript. Skipping exon 23 would 
produce the highest single exon benefit for small arrangement mutations affecting 39 cases.  
Figure 9 shows the final count of restored cases for each exon in all DMD mutations. It 
closely resembles the shape of the graph in figure 6 as most of the total mutations are deletions. 
Exon 51 still reframes the largest number of cases at 1012, while exons 45 and 53 also contribute 
to restoring 645 and 724, respectively. There are two large clusters of highly influential exons 
from exon 43 to 46 and then from 50 to 53. These eight exons combine to theoretically reframe 
3,797 cases, approximately 53.1% of the total 7150 cases.  
  
 
6. Future Directions 
An extension of this study is necessary in order to understand the complete applicability 
of exon skipping in DMD. This study looked only at single exon skips and does not address the 
possibility of skipping multiple consecutive exons at once. While the ability to skip multiple 
exons would presumably be of much greater difficulty, it would theoretically allow for a larger 
portion of mutations to be reframed. A study over this topic would likely require more intense 
programming.   
This study was under the operational assumption that the functionality of the protein 
would not be affected regardless of where the exon deletions took place. Instead, it looked 
strictly at restoring the reading-frame. In reality, there are multiple regions of the gene that 
encode fundamental parts of the dystrophin protein and thus cannot not afford to be skipped; 
however, the hotspot region is usually considered fairly dispensable. A future study would look 
at the effects of this concept on this technique’s applicability.  
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7. Conclusion 
Overall, the data suggests gene editing to be very applicable to Duchenne muscular 
dystrophy. With only skipping one exon at a time, a total of just over 50% of all the recorded 
mutations could have a shift back into the correct reading-frame.  In particular, skipping exon 51 
alone was calculated to reframe 14% of the total mutations. Exon skipping holds the most 
promise for deletions largely because deletions make up the majority of the mutations; however, 
exon skipping for duplications and small rearrangements create other difficulties as well. This 
study has demonstrated the theoretical applicability of CRISPR-mediated exon skipping in 
Duchenne muscular dystrophy based on restorations in the reading frame. While providing 
groundwork for an extension of this study, it has highlighted a few key exons which, if targeted, 
have the potential to help many people suffering from DMD. While these numbers are 
theoretical and are expected to decrease slightly as other factors (exon location and technology 
limitations) are considered, this research has effectively illustrated its potential.  
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